RPM Access Act
Summary
The RPM Access Act (HR3108) was reported out of the House committee with a unanimous 39-0 vote on July 15, 2026, awaiting floor action. It conditions Medicare payment for remote patient monitoring on real-time practitioner availability, EHR-compatible data transmission, and CMS cost-savings reporting. This creates a regulatory floor that legitimizes the RPM market, benefiting pure-play telehealth vendors like Teladoc ($TDOC) and Amwell ($AMWL), as well as EHR-integrated health IT providers like GE HealthCare ($GEHC) and Oracle Health/Cerner ($CERN).
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.The RPM Access Act was reported out of committee with a unanimous 39-0 vote, indicating strong bipartisan support and high likelihood of passage.
- 2.The bill conditions Medicare RPM payment on real-time availability, EHR compatibility, and CMS reporting, creating a regulatory floor that legitimizes the RPM market.
- 3.Pure-play telehealth vendors ($TDOC, $AMWL) and EHR-integrated health IT providers ($GEHC, $CERN) are structural beneficiaries.
Market Implications
The RPM Access Act's unanimous committee vote and bipartisan support create a clear regulatory catalyst for the telehealth and RPM sector. Teladoc ($TDOC) and Amwell ($AMWL) are the most direct beneficiaries, as their core RPM platforms will see increased adoption from Medicare providers seeking compliant solutions. GE HealthCare ($GEHC) and Oracle Health/Cerner benefit from the EHR compatibility mandate, which increases the value of their health IT platforms. The bill does not authorize new spending, but the regulatory standardization reduces uncertainty and could drive a multi-year adoption cycle. No real market data is provided, so no specific price movements are cited.
Full Analysis
The RPM Access Act (HR3108) was ordered to be reported out of committee on July 15, 2026, with a unanimous 39-0 vote, signaling strong bipartisan support. The bill is currently awaiting floor action in the House. It conditions Medicare payment for remote patient monitoring (RPM) services on three requirements: (1) the ability of certain health care practitioners to be available in real time to respond to detected anomalies; (2) the use of a system that can transmit relevant data in a format compatible with electronic health records (EHRs); and (3) reporting of such data to CMS to evaluate cost savings. The bill also establishes a floor for certain payment calculations and requires CMS to report on cost savings and expenses.
The money trail is indirect: the bill does not authorize or appropriate new funding. Instead, it sets conditions for Medicare reimbursement, which is a multi-billion-dollar annual payment stream. By standardizing RPM requirements, the bill creates a regulatory floor that legitimizes the RPM market, potentially expanding the addressable market for RPM vendors. The mechanism is regulatory standardization, not direct spending. The bill's impact is on reimbursement eligibility, which can drive adoption among Medicare beneficiaries and providers.
There is no convergence data provided, so this analysis focuses solely on the bill's direct impact. The bill's bipartisan support (9 cosponsors, including Democrats and Republicans) and unanimous committee vote suggest strong momentum for passage.
Structural winners are pure-play telehealth and RPM vendors like Teladoc ($TDOC) and Amwell ($AMWL), which have existing RPM platforms that can be adapted to meet the new standards. Hims & Hers ($HIMS) also benefits but with lower confidence due to its current focus on direct-to-consumer telehealth. Health IT vendors like GE HealthCare ($GEHC) and Oracle Health/Cerner benefit from the EHR compatibility requirement, as RPM data must flow into their systems. No clear structural losers emerge, as the bill sets a floor rather than imposing penalties.
The timeline: the bill has been reported out of committee and awaits floor action in the House. Given the unanimous committee vote and bipartisan support, passage in the House is likely. It would then need to pass the Senate and be signed by The President. The 119th Congress runs through 2027, so there is ample time for passage.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
Conditions Medicare payment for remote patient monitoring (RPM) on real-time practitioner availability, EHR-compatible data transmission, and CMS cost-savings reporting.
Who must act
Medicare-participating healthcare practitioners and RPM technology vendors.
What happens
RPM services must meet new interoperability and real-time response standards to qualify for Medicare reimbursement, increasing compliance costs but also creating a regulatory floor that legitimizes the RPM market.
Stock impact
Teladoc's primary revenue stream is virtual care and RPM; the bill's standardization of RPM requirements directly validates its business model and may drive adoption among Medicare beneficiaries, expanding its addressable market.
What the bill does
Same as above: conditions Medicare RPM payment on real-time availability, EHR compatibility, and CMS reporting.
Who must act
Medicare-participating healthcare practitioners and RPM technology vendors.
What happens
RPM services must meet new interoperability and real-time response standards to qualify for Medicare reimbursement, increasing compliance costs but also creating a regulatory floor that legitimizes the RPM market.
Stock impact
Amwell's platform is heavily focused on virtual care and RPM for health systems; the bill's EHR compatibility requirement aligns with its existing integration capabilities, potentially increasing contract wins with Medicare-focused providers.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
A bill to amend title XVIII of the Social Security Act to expand access to psychological and behavioral health services.
Precision Brain Health Research Act of 2026
To amend title XXVII of the Public Health Service Act and title XIX of the Social Security Act to require coverage of Alzheimer's biomarker testing under group health plans, group and individual health insurance coverage, and the Medicaid program.
EVEST Act
Saving Lives and Reducing Health Care Waste by Improving Diagnosis in Medicine Act
Commander John Scott Hannon Veterans Mental Health Care Improvement Act of 2019
Veterans STAND Act
VA Fiscal Management Modernization Act
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Securing America’s Defense Supply Chains and Ensuring Domestic Acquisition of Critical Materials
This executive order restricts waivers for foreign-sourced critical materials in defense contracts, effective January 1, 2027, and mandates that defense contractors map their supply chains from raw materials to end products, vet subcontractors for risks, and prohibit covered materials from unreliable foreign suppliers. It directs the Secretary of War to enforce strict compliance, including requiring mitigation plans for any non-compliant materials and establishing penalties for fraud or willful noncompliance.
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →